UBS Group’s Natural Health Trends NHTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $43.9K | Sell |
15,730
-11,974
| -43% | -$40K | ﹤0.01% | 7454 |
|
|
2025
Q4 | $85.6K | Buy |
27,704
+23,580
| +572% | +$85.5K | ﹤0.01% | 6981 |
|
|
2025
Q3 | $18.5K | Buy |
4,124
+62
| +2% | +$282 | ﹤0.01% | 8205 |
|
|
2025
Q2 | $17.6K | Sell |
4,062
-429
| -10% | -$2.06K | ﹤0.01% | 8525 |
|
|
2025
Q1 | $22.7K | Buy |
4,491
+127
| +3% | +$631 | ﹤0.01% | 8138 |
|
|
2024
Q4 | $20.2K | Buy |
4,364
+3,161
| +263% | +$17.1K | ﹤0.01% | 7864 |
|
|
2024
Q3 | $7.16K | Buy |
+1,203
| New | +$8.24K | ﹤0.01% | 7932 |
|
|
2024
Q1 | – | Sell |
-1,446
| Closed | -$8.47K | – | 9795 |
|
|
2023
Q4 | $8.47K | Buy |
+1,446
| New | +$7.95K | ﹤0.01% | 7552 |
|
|
2023
Q2 | – | Sell |
-696
| Closed | -$3.44K | – | 9402 |
|
|
2023
Q1 | $3.44K | Buy |
+696
| New | +$3.44K | ﹤0.01% | 8319 |
|
|
2022
Q2 | – | Sell |
-2,048
| Closed | -$15K | – | 10711 |
|
|
2022
Q1 | $15K | Sell |
2,048
-802
| -28% | -$5.83K | ﹤0.01% | 7833 |
|
|
2021
Q4 | $19K | Buy |
+2,850
| New | +$20.4K | ﹤0.01% | 7908 |
|
|
2021
Q2 | – | Sell |
-1
| Closed | – | – | 9661 |
|
|
2021
Q1 | $0 | Sell |
1
-4,908
| -100% | -$31.4K | ﹤0.01% | 9315 |
|
|
2020
Q4 | $24K | Buy |
4,909
+2,808
| +134% | +$15.6K | ﹤0.01% | 6808 |
|
|
2020
Q3 | $12K | Hold |
2,101
| – | – | ﹤0.01% | 6705 |
|
|
2020
Q2 | $12K | Sell |
2,101
-1,119
| -35% | -$5.79K | ﹤0.01% | 6892 |
|
|
2020
Q1 | $11K | Buy |
3,220
+1,119
| +53% | +$4.53K | ﹤0.01% | 6874 |
|
|
2019
Q4 | $11K | Sell |
2,101
-2,144
| -51% | -$13.7K | ﹤0.01% | 7240 |
|
|
2019
Q3 | $30K | Buy |
+4,245
| New | +$31.1K | ﹤0.01% | 6492 |
|
|
2019
Q2 | – | Sell |
-1,096
| Closed | -$14K | – | 8054 |
|
|
2019
Q1 | $14K | Sell |
1,096
-3,814
| -78% | -$56.9K | ﹤0.01% | 6590 |
|
|
2018
Q4 | $91K | Buy |
4,910
+25
| +0.5% | +$550 | ﹤0.01% | 5613 |
|
|
2018
Q3 | $114K | Buy |
4,885
+1,597
| +49% | +$39.1K | ﹤0.01% | 5487 |
|
|
2018
Q2 | $82K | Buy |
3,288
+578
| +21% | +$12.1K | ﹤0.01% | 5591 |
|
|
2018
Q1 | $52K | Sell |
2,710
-3,211
| -54% | -$54.4K | ﹤0.01% | 5685 |
|
|
2017
Q4 | $90K | Buy |
5,921
+1,073
| +22% | +$20.2K | ﹤0.01% | 5433 |
|
|
2017
Q3 | $116K | Buy |
4,848
+506
| +12% | +$11.5K | ﹤0.01% | 5229 |
|
|
2017
Q2 | $121K | Sell |
4,342
-1,047
| -19% | -$29.9K | ﹤0.01% | 5049 |
|
|
2017
Q1 | $156K | Sell |
5,389
-1,103
| -17% | -$29.6K | ﹤0.01% | 4799 |
|
|
2016
Q4 | $161K | Buy |
6,492
+5,100
| +366% | +$128K | ﹤0.01% | 4950 |
|
|
2016
Q3 | $39K | Sell |
1,392
-554
| -28% | -$17.2K | ﹤0.01% | 5712 |
|
|
2016
Q2 | $55K | Buy |
1,946
+225
| +13% | +$7.35K | ﹤0.01% | 5451 |
|
|
2016
Q1 | $57K | Sell |
1,721
-6,721
| -80% | -$182K | ﹤0.01% | 5399 |
|
|
2015
Q4 | $283K | Buy |
+8,442
| New | +$372K | ﹤0.01% | 4400 |
|
|
2015
Q3 | – | Sell |
-1,287
| Closed | -$53K | – | 8547 |
|
|
2015
Q2 | $53K | Sell |
1,287
-980
| -43% | -$29K | ﹤0.01% | 5959 |
|
|
2015
Q1 | $41K | Buy |
+2,267
| New | +$35.8K | ﹤0.01% | 6239 |
|
Other funds holding NHTC
VCM
VFT
BCM
UBS Group's NHTC Position: Q1 2026 in Review
UBS Group reduced its Natural Health Trends (NHTC) stake by 43% in Q1 2026, selling an estimated $40K and leaving 15,730 shares worth $43.9K. The position accounts for ﹤0.01% of the portfolio, ranked #7454.
UBS Group first reported a position in NHTC in Q1 2015 and has held it in 34 quarters since. The position peaked at $283K in Q4 2015. 23 funds tracked by Wall St. Rank hold NHTC as of Q1 2026.
- UBS Group held 15,730 shares of Natural Health Trends worth $43.9K as of Q1 2026.
- UBS Group sold 11,974 Natural Health Trends shares in Q1 2026, an estimated $40K.
- Natural Health Trends made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #7454 holding.
- UBS Group first reported a position in Natural Health Trends in Q1 2015 and has held it in 34 quarters since.
- UBS Group's Natural Health Trends position peaked at $283K in Q4 2015.
- 23 funds tracked by Wall St. Rank held Natural Health Trends as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.